2-[4-[2-(2,4-Dichlorophenyl)ethyl]anilino]-5-nitrobenzoic acid | 313676-14-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 2-[4-[2-(2,4-Dichlorophenyl)ethyl]anilino]-5-nitrobenzoic acid
• CAS: 313676-14-1
• 化学式: C₂₁H₁₆Cl₂N₂O₄
• 分子量: 431.275
• InChiKey: FFPDIUXOMBIOKQ-UHFFFAOYSA-N

物化性质

• 沸点：
  576.4±50.0 °C(Predicted)
• 密度：
  1.450±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.8
• 重原子数：
  29
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  95.2
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  2-氟-5-硝基苯甲酸 、 4-(2,4-dichlorophenethyl)aniline 在 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 为溶剂， 生成 2-[4-[2-(2,4-Dichlorophenyl)ethyl]anilino]-5-nitrobenzoic acid
  参考文献：
  名称：

  取代的N-苯基邻氨基苯甲酸类似物作为淀粉样聚集抑制剂的合成及其构效关系

  摘要：

  认为β-淀粉样蛋白聚集是阿尔茨海默氏病发展中的重要事件。在我们鉴定β-淀粉样蛋白聚集抑制剂的研究过程中，合成了一系列N-苯基邻氨基苯甲酸类似物，并研究了β-淀粉样蛋白抑制活性。讨论了这些类似物的合成，结构-活性关系以及体内活性。

  DOI：

  10.1016/j.bmcl.2008.12.049

文献信息

• Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
  申请人：——

  公开号：US20040220235A1

  公开（公告）日：2004-11-04

  The present invention provides a method of treating Alzheimer's disease using a compound of Formula I 1 Also provided is a method of inhibiting the aggregation of amyloid proteins using a compound of Formula I and a method of imaging amyloid deposits, as well as new compounds of Formula I.

  本发明提供了一种利用I1式化合物治疗阿尔茨海默病的方法。还提供了一种利用I式化合物抑制淀粉样蛋白聚集的方法，以及一种成像淀粉样沉积物的方法，以及新的I式化合物。
• NORBORNENE DERIVATIVE AND NORBORNENE POLYMER OBTAINED THEREFROM THROUGH RING-OPENING POLYMERIZATION
  申请人：JSR Corporation

  公开号：EP1435350A1

  公开（公告）日：2004-07-07

  A novel norbornene derivative represented by a general formula (1m) shown below is provided. By conducting a ring opening polymerization of this norbornene derivative, or by performing a subsequent hydrogenation following the ring opening polymerization, a ring opening polymer or a hydrogenated product thereof with an excellent low birefringence can be obtained. [wherein, at least one of R1 to R4 is a group selected from the group consisting of groups represented by a general formula (1-1) shown below and groups represented by a general formula (1-2) shown below] [wherein, at least one of RA, RB and Z is a group represented by the formula -C(O)O-].

  本发明提供了一种由下图所示通式（1m）表示的新型降冰片烯衍生物。通过对这种降冰片烯衍生物进行开环聚合反应，或在开环聚合反应后进行氢化反应，可获得具有极佳低双折射性的开环聚合物或其氢化产物。 [其中，R1 至 R4 中至少有一个是选自下图所示通式（1-1）所代表的基团和下图所示通式（1-2）所代表的基团所组成的基团。］ [其中，RA、RB 和 Z 中至少有一个是由式 -C(O)O- 所代表的基团]。
• METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP1225886A2

  公开（公告）日：2002-07-31
• NORBORNENE DERIVATIVE AND NORBORNENE POLYMER OBTAINED THEREFROM THROUGH RING OPENING POLYMERIZATION
  申请人：——

  公开号：US20040242824A1

  公开（公告）日：2004-12-02

  A novel norbornene derivative represented by a general formula (1m) shown below is provided. By conducting a ring opening polymerization of this norbornene derivative, or by performing a subsequent hydrogenation following the ring opening polymerization, a ring opening polymer or a hydrogenated product thereof with an excellent low birefringence can be obtained. 1 [wherein, at least one of R 1 to R 4 is a group selected from the group consisting of groups represented by a general formula (1-1) shown below and groups represented by a general formula (1-2) shown below] 2 [wherein, at least one of R A , R B and Z is a group represented by the formula —C(O)O—].
• US6846890B2
  申请人：——

  公开号：US6846890B2

  公开（公告）日：2005-01-25